Lexicon Pharmaceuticals (LXRX) Enterprise Value Growth (1y) (2011 - 2026)
Lexicon Pharmaceuticals (LXRX) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.41% |
| Dec 31, 2025 | 59.56% |
| Sep 30, 2025 | 55.12% |
| Jun 30, 2025 | 55.15% |
| Mar 31, 2025 | 45.21% |
| Dec 31, 2024 | -39.95% |
| Sep 30, 2024 | -18.29% |
| Jun 30, 2024 | -20.73% |
| Mar 31, 2024 | -235.67% |
| Dec 31, 2023 | -22.89% |
| Sep 30, 2023 | -60.37% |
| Jun 30, 2023 | -314.31% |
| Mar 31, 2023 | -22.47% |
| Dec 31, 2022 | -59.50% |
| Sep 30, 2022 | -12.64% |
| Jun 30, 2022 | 47.71% |
| Mar 31, 2022 | 38.81% |
| Dec 31, 2021 | 43.04% |
| Sep 30, 2021 | -8.50% |
| Jun 30, 2021 | 41.30% |